Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27663860)

Published in FASEB J on September 23, 2016

Authors

Mikako Hisamichi1, Atsuko Kamijo-Ikemori2,3, Takeshi Sugaya1, Daisuke Ichikawa1, Takayuki Natsuki4, Seiko Hoshino3, Kenjiro Kimura5, Yugo Shibagaki1

Author Affiliations

1: Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
2: Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan; a2kamijo@marianna-u.ac.jp.
3: Department of Anatomy, St. Marianna University School of Medicine, Kawasaki, Japan.
4: Institute for Ultrastructural Morphology, St. Marianna University School of Medicine, Kawasaki, Japan.
5: Department of Internal Medicine, Japan Community Health Care Organization, Tokyo Takanawa Hospital, Tokyo, Japan.

Articles cited by this

The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev (2007) 6.79

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA (2001) 4.75

Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis (1992) 3.73

Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71

Pathophysiology of progressive nephropathies. N Engl J Med (1998) 3.61

Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol (2004) 3.03

Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest (2005) 2.59

Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet (1968) 2.58

Immunohistochemical localization of ANG II AT1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol (1997) 2.15

Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem (1995) 2.11

Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am J Physiol (1999) 1.79

Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction. EMBO J (2008) 1.71

Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol (2004) 1.56

Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med (2004) 1.48

Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion. J Am Soc Nephrol (2015) 1.43

Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis. J Clin Invest (2009) 1.41

Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol (1997) 1.37

Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol (2003) 1.35

Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res (1975) 1.27

Immunohistochemical localization of rat angiotensin II AT1 receptor. Am J Physiol (1993) 1.23

Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest (1999) 1.21

Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage. Am J Pathol (2009) 1.20

Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial. J Lab Clin Med (2005) 1.16

Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity. Am J Physiol Renal Physiol (2011) 1.13

Expression of type 1 angiotensin II receptor subtypes and angiotensin II-induced calcium mobilization along the rat nephron. J Am Soc Nephrol (1997) 1.13

Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int (1992) 1.10

Proposed update of angiotensin receptor nomenclature. Hypertension (1995) 1.01

Stretch-activation of angiotensin II type 1a receptors contributes to the myogenic response of mouse mesenteric and renal arteries. Circ Res (2014) 0.98

Extracellular signal-regulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity. Hypertension (2009) 0.97

Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension (1994) 0.97

Absence of renin suppression by deoxycorticosterone acetate in rats. Am J Physiol (1969) 0.94

Regulation of renin gene expression in hypertensive rats. Hypertension (1988) 0.93

Mesangial AT1 receptors: expression, signaling, and regulation. J Am Soc Nephrol (1999) 0.92

Molecular mechanisms of renal blood flow autoregulation. Curr Vasc Pharmacol (2014) 0.92

Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity. Am J Pathol (2011) 0.91

Differential expression of collagen IV isoforms in experimental glomerulosclerosis. J Pathol (1998) 0.88

Differential expression of glomerular extracellular matrix and growth factor mRNA in rapid and slowly progressive glomerulosclerosis: studies in mice transgenic for native or mutated growth hormone. Lab Invest (1997) 0.83

Cysteinyl leukotriene 1 receptors as novel mechanosensors mediating myogenic tone together with angiotensin II type 1 receptors-brief report. Arterioscler Thromb Vasc Biol (2014) 0.81

Novel role of mechanosensitive AT1B receptors in myogenic vasoconstriction. Pflugers Arch (2013) 0.81

Efficacy and safety of angiotensin receptor blockers in older patients: a meta-analysis of randomized trials. Am J Hypertens (2014) 0.80

Angiotensin II maintains the structure and function of glomerular mesangium via type 1a receptor. What we have learned from null mutant mice minus the angiotensin II type 1a receptor gene. Virchows Arch (1998) 0.79

Variations in arterioles in spontaneously hypertensive rats. Morphometric analysis of afferent and efferent arterioles. Virchows Arch A Pathol Anat Histopathol (1989) 0.79

Differential response of glomerular epithelial and mesangial cells after subtotal nephrectomy. Kidney Int (1998) 0.79

Renoprotective effect of renal liver-type fatty acid binding protein and angiotensin II type 1a receptor loss in renal injury caused by RAS activation. Am J Physiol Renal Physiol (2014) 0.78

Renal liver-type fatty acid binding protein attenuates angiotensin II-induced renal injury. Hypertension (2012) 0.78

Location and action of angiotensin II type 1 receptor in the renal microcirculation. Kidney Int Suppl (1997) 0.78

Morphometric analysis of arteriolar diameters in experimental nephropathies: application of microvascular casts. Virchows Arch A Pathol Anat Histopathol (1990) 0.78

Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury. Am J Physiol Renal Physiol (2014) 0.76